Earl M. Collier, Jr.

Duke Collier joined Genzyme in 1997 after having served as an outside lawyer for the company since 1990. He is responsible for managing Genzyme’s cardiovascular, oncology and genetics businesses, as well as its multiple sclerosis program. Before he joined Genzyme, Mr. Collier was president of Vitas Healthcare Corporation, and a partner at the Washington, D.C. law firm Hogan and Hartson. He also served as deputy administrator for the Health Care Financing Administration in Baltimore, M.D., during the Carter administration. Mr. Collier earned a J.D. at the University of Virginia Law School and a B.A. at Yale University.